Bionano Genomics, Inc.
BNGO
$1.18
-$0.02-1.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 22.19% | -15.90% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 22.19% | -15.90% | |||
| Cost of Revenue | 12.29% | -24.54% | |||
| Gross Profit | 32.66% | -4.32% | |||
| SG&A Expenses | 6.67% | -7.99% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.52% | -11.54% | |||
| Operating Income | 8.60% | 7.49% | |||
| Income Before Tax | 10.58% | -5.00% | |||
| Income Tax Expenses | -30.00% | -71.43% | |||
| Earnings from Continuing Operations | 10.60% | -4.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 10.60% | -4.66% | |||
| EBIT | 8.60% | 7.49% | |||
| EBITDA | 12.01% | 12.85% | |||
| EPS Basic | 14.99% | 1.87% | |||
| Normalized Basic EPS | 14.98% | 1.56% | |||
| EPS Diluted | 14.99% | 1.87% | |||
| Normalized Diluted EPS | 14.98% | 1.56% | |||
| Average Basic Shares Outstanding | 5.16% | 6.66% | |||
| Average Diluted Shares Outstanding | 5.16% | 6.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||